최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Molecular and cellular endocrinology, v.464, 2018년, pp.28 - 33
Alquraini, Hussain (Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA) , Auchus, Richard J. (Division of Metabolism, Endocrinology, and Diabetes, Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA)
Abstract Androgenic-anabolic steroids (AAS) are potent and widely used performance-enhancing substances (PES). Since the International Olympic Committee (IOC) began testing athletes for AAS in the 1970s, athletes and their teams have endeavored to beat the system to avoid doping violations and/or s...
J. Clin. Endocrinol. Metab. Basaria 95 1533 2010 10.1210/jc.2009-1579 Androgen abuse in athletes: detection and consequences
J. Clin. Endocrinol. Metab. Bhasin 95 2536 2010 10.1210/jc.2009-2354 Testosterone therapy in men with androgen deficiency syndromes: an endocrine society clinical practice guideline
N. Engl. J. Med. Bhasin 335 1 1996 10.1056/NEJM199607043350101 The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men
J. Mass Spectrom. Botre 43 903 2008 10.1002/jms.1455 New and old challenges of sports drug testing
Br. J. Pharmacol. Cadwallader 161 1 2010 10.1111/j.1476-5381.2010.00789.x The abuse of diuretics as performance-enhancing drugs and masking agents in sport doping: pharmacology, toxicology and analysis
J. Endocrinol. Cowan 131 147 1991 10.1677/joe.0.1310147 Effect of administration of human chorionic gonadotrophin on criteria used to assess testosterone administration in athletes
Int. J. Sport. Med. de Boer 12 46 1991 10.1055/s-2007-1024654 Doping control of testosterone and human chorionic gonadotrophin: a case study
Clin. Chem. Dehennin 40 106 1994 10.1093/clinchem/40.1.106 Detection of simultaneous self-administration of testosterone and epitestosterone in healthy men
J. Clin. Endocrinol. Metab. Grunstein 68 352 1989 10.1210/jcem-68-2-352 Neuroendocrine dysfunction in sleep apnea: reversal by continuous positive airways pressure therapy
J. Clin. Endocrinol. Metab. Jakobsson 91 687 2006 10.1210/jc.2005-1643 Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism
J. Steroid Biochem. Mol. Biol. Krone 121 496 2010 10.1016/j.jsbmb.2010.04.010 Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS)
J. Mass Spectrom. Mareck 43 854 2008 10.1002/jms.1457 Factors influencing the steroid profile in doping control analysis
Pharmacogenomics Marsth 5 835 2004 10.1517/14622416.5.7.835 Pharmacogenetics of irinotecan toxicity
Endocr. Rev. Miller 32 81 2011 10.1210/er.2010-0013 The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders
Endocr. Rev. Pope 35 341 2014 10.1210/er.2013-1058 Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement
Br. J. Sports Med. Saudan 1 40 Suppl i21 2006 10.1136/bjsm.2006.027482 Testosterone and doping control
Bailliere’s Best. Pract. Res. Clin. Endocrinol. Metab. Saugy 14 111 2000 10.1053/beem.2000.0058 Test methods: anabolics
J. Clin. Endocrinol. Metab. Schulze 93 2500 2008 10.1210/jc.2008-0218 Doping test results dependent on genotype of uridine diphospho-glucuronosyl transferase 2B17, the major enzyme for testosterone glucuronidation
Endocr. Rev. Simpson 15 342 1994 Aromatase cytochrome P450, the enzyme responsible for estrogen biosynthesis
N. Engl. J. Med. Sonino 317 812 1987 10.1056/NEJM198709243171307 The use of ketoconazole as an inhibitor of steroid production
Endocrinol. Metab. Clin. North Am. Sottas 39 59 2010 10.1016/j.ecl.2009.11.003 Endogenous steroid profiling in the athlete biological passport
Ther. Drug Monit. Thevis 29 236 2007 10.1097/FTD.0b013e31803bb85d Doping-control analysis of the 5α-reductase inhibitor finasteride: determination of its influence on urinary steroid profiles and detection of its major urinary metabolite
Endocrinology Turgeon 142 778 2001 10.1210/endo.142.2.7958 Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members
J. Anal. Toxicol. van de Kerkhof 24 102 2000 10.1093/jat/24.2.102 Evaluation of testosterone/epitestosterone ratio influential factors as determined in doping analysis
WADA 1 2015 World Anti-Doping World Anti-Doping Code
World Anti-doping Agency 2015
해당 논문의 주제분야에서 활용도가 높은 상위 5개 콘텐츠를 보여줍니다.
더보기 버튼을 클릭하시면 더 많은 관련자료를 살펴볼 수 있습니다.
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.